Florida Senate - 2015                        COMMITTEE AMENDMENT
       Bill No. CS for SB 614
       
       
       
       
       
       
                                Ì851976UÎ851976                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  04/01/2015           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Regulated Industries (Flores) recommended the
       following:
       
    1         Senate Substitute for Amendment (966182) (with title
    2  amendment)
    3  
    4         Delete line 537
    5  and insert:
    6         (6)(a) The board shall appoint a committee to recommend
    7  whether a formulary of controlled substances that an advanced
    8  registered nurse practitioner may not prescribe or may prescribe
    9  only for specific uses or subject to specific limitations is
   10  necessary to protect the health, safety, and welfare of the
   11  public. The committee shall consist of at least three advanced
   12  registered nurse practitioners, including a certified registered
   13  nurse anesthetist, a certified nurse midwife, and a nurse
   14  practitioner; at least one physician recommended by the Board of
   15  Medicine and one physician recommended by the Board of
   16  Osteopathic Medicine, both of whom have had work experience with
   17  advanced practice registered nurses; and a pharmacist licensed
   18  under chapter 465, but not licensed under chapter 458, chapter
   19  459, or this chapter, who shall be selected by the State Surgeon
   20  General. The committee may recommend a formulary applicable to
   21  all advanced registered nurse practitioners, limited by
   22  specialty certification, limited to approved uses of controlled
   23  substances, or subject to other similar restrictions it deems
   24  necessary to protect the health, safety, and welfare of the
   25  public.
   26         (b) If the committee recommends that a formulary be
   27  established, the board shall adopt a formulary by rule. Only the
   28  board may add to, delete from, or modify the formulary. A person
   29  who requests the addition, deletion, or modification of a
   30  controlled substance listed on the formulary has the burden of
   31  proof to show cause why the change should be made. The board
   32  shall post notice of any proposed, pending, or adopted changes
   33  to the formulary on its website.
   34         (c) The board shall initiate rulemaking, if required to
   35  implement the committee’s initial recommendation, no later than
   36  October 1, 2015.
   37         (d) If adopted by board rule, the formulary authorized in
   38  this subsection does not apply to orders for medications
   39  pursuant to subparagraph (4)(a)3. or subparagraph (4)(a)4.
   40  ================= T I T L E  A M E N D M E N T ================
   41  And the title is amended as follows:
   42         Delete line 31
   43  and insert:
   44         monitor and alter drug therapies; requiring the Board
   45         of Nursing to appoint a committee to recommend whether
   46         adoption of a formulary of controlled substances that
   47         may be prescribed by an advanced registered nurse
   48         practitioner is needed; specifying the membership of
   49         the committee; providing parameters for the
   50         recommendations of the committee; requiring that any
   51         formulary be adopted by board rule; specifying the
   52         process for amending the formulary and imposing a
   53         burden of proof; requiring the board to post notice of
   54         proposed, pending, or adopted changes to the formulary
   55         on its website; specifying a deadline for initiating
   56         any required rulemaking; limiting the formulary’s
   57         application in certain instances; amending s. 464.018,